The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumInsights - On Monday after the close, Cempra (CEMP) updated investors on its pipeline progress. We saw no major surprises and consider the update net-neutral, if not –positive. Read … Continue Reading
Read nowResearch - Although the stock is getting away from us as we await feedback from the company (more below), for those not already involved, Progenics (PGNX) is … Continue Reading
PremiumInsights - AcelRx Pharmaceuticals (ACRX) announced on Monday a partnership with Grunenthal GmbH for the commercialization of Zalviso, the company’s patient-controlled analgesia product, in Europe and Australia. AcelRx will receive $30 … Continue Reading
Read nowInsights - PropThink readers who followed us into Enanta Pharmaceuticals (ENTA) in July saw their money double through this week. AbbVie (ABBV), which uses an Enanta-developed hepatitis drug (the protease … Continue Reading
Read nowInsights - Coronado Biosciences (CNDO) on Thursday after the bell announced that an early and small study of its lead candidate, TSO (Trichuris suis ova, CNDO-201, or … Continue Reading
PremiumInsights - Sarepta Therapeutics (SRPT) traded as high as $20.79 on Thursday morning following comments from the director of the FDA’s Center for Drug Evaluation and Research (CDER), Janet Woodcock, … Continue Reading
Read nowInsights - Raptor Pharmaceutical Corp. (RPTP) announced it has submitted an investigational new drug application (IND) to the U.S. Food and Drug Administration (FDA) for the clinical … Continue Reading
Read now
